Comparison of brain-derived versus conventional pTau biomarkers in CSF and plasma for detecting Alzheimer’s disease.

Trudel L, Therriault J, Ghisays V, Macedo AC, Gauthier S, Vitali P, Benedet AL, Zetterberg H, Su Y, Singh A, Marques T, Denkinger MN, Seyfried NT, Levey AI, Weiner MW, Van Keuren-Jensen K, Reiman EM, Ashton NJ, Rosa-Neto P. Comparison of brain-derived versus conventional pTau biomarkers in CSF and plasma for detecting Alzheimer’s disease. Brain Commun. 2026 Oct 7;8(5):fcag376. doi: 10.1093/braincomms/fcag376. PMID: 42889489; PMCID: PMC13669629.